Skip to main content
  •   

    The Dead Bag Syndrome

    AAO 2022 Video Program
    Cataract/Anterior Segment, Complications, IOLs and Implantation

    A "dead bag syndrome" has been recently described, in which the capsular bag appears to be clear many years after surgery, becoming diaphanous and floppy and unable to support the intraocular lens within it. The exact etiology of the syndrome is unknown. The findings of cases suspected to be dead bag syndrome are described in this video and illustrated through surgical video clips, clinical photographs, and histopathological evaluation.

    Financial Disclosures: Dr. Samuel Masket discloses financial relationships with Alcon Laboratories, Inc. (Consultant/Advisor); CAPSULaser (Consultant/Advisor); Haag Streit USA (Consultant/Advisor, Patents/Royalty); Morcher GmbH (Patents/Royalty). 

    Dr. Nick Mamalis discloses financial relationships with Alcon Laboratories, Inc. (Grant Support); Anew Optics, Inc. (Consultant/Advisor, Grant Support); Atia Vision (Grant Support); Carl Zeiss Meditec (Grant Support); ClarVista Medical (Grant Support); Cristalens Industrie (Grant Support); Hoya Corporation (Grant Support); LensGen Inc (Grant Support); Long Bridge Medical (Grant Support); Medicontur International SA (Grant Support); Merck & Co, Inc. (Grant Support); OcuMetrics (Grant Support).

    Dr. Gregory Ogawa discloses a financial relationship with VisionQuest Biomedical (Stock Options - Public or Private).

    Dr. Liliana Werner discloses financial relationships with Spyglass Pharma (Grant Support); Shifamed/Atia (Grant Support); Perfect Lens, LLC (Grant Support); Ocumetics (Grant Support); Mediphacos (Grant Support); Long Bridge Medical (Grant Support); LensGen Inc (Grant Support); HumanOptics (Grant Support); Hoya Corporation (Consultant/Advisor, Grant Support); Cristalens Industrie (Grant Support); Carl Zeiss Meditec (Grant Support); Bausch + Lomb (Consultant/Advisor, Grant Support); Anew Optics (Grant Support).

    Dr. Jason Jones discloses financial relationships with Glaukos Corporation (Grant Support); Ivantis, Inc. (Consultant/Advisor, Lecture Fees/Speaker Bureau, Grant Support); Johnson & Johnson (Consultant/Advisor, Lecture Fees/Speaker Bureau, Grant Support); Perfect Lens, LLC (Consultant/Advisor); Slack (Lecture Fees/Speaker Bureau).

    Dr. Nicole Fram discloses financial relationships with Alcon Laboratories, Inc. (Consultant/Advisor); Aurion (Consultant/Advisor); Avellino Labs (Consultant/Advisor); Beaver-Visatec International, Inc. (Lecture Fees/Speaker Bureau); Carl Zeiss Meditec (Consultant/Advisor, Lecture Fees/Speaker Bureau, Grant Support); CorneaGen  (Consultant/Advisor, Lecture Fees/Speaker Bureau, Grant Support, Stock Options - Public or Private); Glaukos Corporation (Lecture Fees/Speaker Bureau); Johnson & Johnson Vision (Consultant/Advisor, Lecture Fees/Speaker Bureau); Lensar (Consultant/Advisor); Ocular Science (Consultant/Advisor, Stock Options - Public or Private); Ocular Therpeutix (Grant Support); Orasis Pharmaceuticals Inc (Consultant/Advisor, Stock Options - Public or Private); Vital Tears (Lecture Fees/Speaker Bureau).